Скачать или смотреть Why 90% of good ideas fail | Dr. Gary Ansel on Pipeline & People | Ep. 27

How do great medical technologies actually make it to market?

In this episode, Dr. Gary Ansel, Co-Founder of Healthcare Inroads, breaks down what separates successful medtech commercialization from costly dead ends.

With decades of experience as a vascular interventionalist, system chief, and advisor, Gary shares the realities of value analysis committees, why 90% of good ideas never make it to the shelf, and how startups can avoid the biggest pitfalls before launch.

We discuss:
• How to identify if your device should go to market
• Why clinical value isn’t enough without financial clarity
• How to pitch to hospital C-suites (and avoid getting blocked)
• The “mock panel” process that gets products FDA- and hospital-ready
• The role of physician-led market research in accelerating adoption

If you’re in MedTech, healthcare venture, or hospital innovation, this is a masterclass on commercial readiness.

📘 Chapters (to include at the bottom of the YouTube description)

00:00 – Introduction: Who is Dr. Gary Ansel?
01:25 – How Healthcare Inroads Helps MedTech Innovators
03:10 – The Rise of Value Analysis Committees
04:45 – Why So Many Great Ideas Never Make It to Market
06:30 – Common Pitfalls in Commercialization Strategy
08:20 – How to Test Market Readiness Before You Build
10:30 – Case Study: The Central Line Success Story
13:00 – The Power of the “Mock Panel” Process
15:10 – Aligning Regulatory, Reimbursement, and Market Strategy
18:00 – How to Speak the Language of the C-Suite
20:00 – What’s Next for Healthcare Inroads
22:00 – MedTech Misconceptions and Entrepreneur Advice
23:20 – Why Founders Should Celebrate Failure
24:00 – Where to Connect with Dr. Ansel